Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer. Geoffroy, K., Mullins-Dansereau, V., Leclerc-Desaulniers, K., Viens, M., & Bourgeois-Daigneault, M. Molecular Therapy: Oncology, 32(3):200826, September, 2024.
Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer [link]Paper  doi  bibtex   
@article{geoffroy_oncolytic_2024,
	title = {Oncolytic vesicular stomatitis virus alone or in combination with {JAK} inhibitors is effective against ovarian cancer},
	volume = {32},
	issn = {29503299},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S2950329924000687},
	doi = {10.1016/j.omton.2024.200826},
	language = {en},
	number = {3},
	urldate = {2025-01-28},
	journal = {Molecular Therapy: Oncology},
	author = {Geoffroy, Karen and Mullins-Dansereau, Victor and Leclerc-Desaulniers, Kim and Viens, Mélissa and Bourgeois-Daigneault, Marie-Claude},
	month = sep,
	year = {2024},
	pages = {200826},
}

Downloads: 0